Respiratory Activities
The Pharmacist's Opportunity to Improve Disease-State Management in Cystic Fibrosis
0290-0000-18-136-H01-P
Participants will gain understanding of the current treatment options for cystic fibrosis and the role of the pharmacist in improving patient adherence and outcomes.
1.50
New and Emerging Treatments for the Care of Patients with EGFR- and ALK-Positive NSCLC
0290-0000-18-111-H01-P
This presentation will review progress made in developing personalized therapeutic approaches to the management of NSCLC, the most common form of lung cancer.
1.00
Optimized Care of Patients With COPD: Pharmacotherapy and Appropriate Use of Inhalers
0290-0000-18-051-H01-P
The faculty panel of this PTCE program will discuss pharmacologic agents in COPD management and other important topics pertaining to COPD.
1.50
Identifying Health–System Pharmacist's Role in Improving Pulmonary Arterial Hypertension and Transitions of Care
0290-0000-17-197-H01-P
This webinar will focus on pulmonary arterial hypertension as a disease state, and treatment guidelines and goals, which require a multidisciplinary approach.
1.00